News & Articles
Selected Filters:
Opaganib by RedHill Biopharma submitted for approval of investigation for COVID-19 treatment
Proposed study intended to evaluate the safety and efficacy of opaganib in up to 60 patients hospitalized with positive SARS-CoV-2 infection and pneumonia in the U.S.
Army of scientists redeployed in search for COVID-19 treatments
The team at the University of Edinburgh believe new therapies could be discovered before a vaccine becomes available
Synthon Biopharmaceuticals relaunches as Byondis
Diagnostics firm distributing COVID-19 test kits in the UK
The new product line includes the MutaPLEX RT-PCR assay and ELISA kits to detect IgM and IgG antibodies
Gold Standard Diagnostics releases three COVID-19 antibody tests
The IgA, IgG, and IgM assays are formatted for optimal functionality in diagnostic laboratories
Lab-based coronavirus test aims to deliver up to 46,000 results a day
The testing capability of Mologic's kits is expected to relieve immediate testing pressures in the UK and Africa
Roche develops new serology test to detect COVID-19 antibodies
The detection of these antibodies could help indicate if a person has gained immunity against the virus and inform treatment decisions
Temperature control solutions to support researchers in fight against COVID-19
Huber's high precision temperature control technology directed towards manufacturing test chemicals and PPE
MedTest Dx manufactures quantitative test for G6PD with COVID-19 applications
The only FDA-approved test that measures G6PD provides key insight to inform drug therapy options
Bio-Rad to launch blood-based immunoassay kit to detect COVID-19 antibodies
The serology immunoassay kit aims to help clinicians diagnose the coronavirus by analyzing the immune response against SARS-CoV-2
AgileBio launches a LIMS package addressed to COVID-19 labs
The new LabCollector LIMS pack aims to increase the rapidity and efficiency in COVID-19 tests management
FDA approves first saliva-based coronavirus test
Emergency use authorization granted for new biomaterial collection approach
Bruker and ANPC partner to support major new frontline response to combat COVID-19 threat
The strategic partnership with Australian National Phenome Centre (ANPC) aims to support the work of their researchers
Ford ramps up PPE production amidst collaboration with Thermo Fisher on COVID-19 test kits
Vehicle manufacturer utilizes infrastructure to expand production to face masks and gowns for frontline medical staff
Formlabs create 3D printed nasal swabs during emergency shortage situation
With medical equipment in short supply, the 3D printing company steps up in coronavirus crisis
Partnership to scale-up GMP manufacturing of a COVID-19 vaccine announced
Alliance for the scale-up of a GMP manufacturing process and production of a coronavirus (SARS-CoV-2) vaccine (ChAdOx1 nCoV-19) formed
SelectScience co-founder named top tech leader
Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis
STEMCELL Technologies helps sequence COVID-19
Canadian biotechnology company STEMCELL Technologies has provided critical support to sequence the coronavirus, accelerating vaccine development
Key considerations when tackling multidrug-resistant organisms to improve time to effective treatment
Watch this on-demand webinar to discover important factors in treatment approaches when confronting antimicrobial resistance
Bio-Rad receives FDA emergency use authorization for droplet digital PCR SARS-CoV-2 test kit
Test runs on Bio-Rad’s QX200 and QXDx ddPCR systems and aims to provide early detection of COVID-19
Scientists identify COVID-19 testing method that delivers accurate results within 25 minutes
A team of academic clinicians from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust identified the novel method “LAMP”
New cannabinoid compound to treat irritable bowel syndrome
Oxford Cannabinoid Technologies has announced the pre-clinical development of a new cannabinoid compound ‘OCT461201’ to treat IBS
Bosch develops rapid test for combating the coronavirus
The test results are designed to enable differential diagnosis in under 2.5 hours
Luminex receives FDA emergency use authorization for COVID-19 diagnostic panel
Recent funding from the BARDA award helped the company accelerate development and validation